Interleukin-12 in Treating Patients With Advanced Cancer
This study has been completed.
Information provided by (Responsible Party):
National Cancer Institute (NCI)
First received: November 1, 1999
Last updated: February 8, 2013
Last verified: May 2001
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Estimated Study Completion Date:||No date given|
|Primary Completion Date:||April 2002 (Final data collection date for primary outcome measure)|
Gollob JA, Mier JW, Veenstra K, McDermott DF, Clancy D, Clancy M, Atkins MB. Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response. Clin Cancer Res. 2000 May;6(5):1678-92.